PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+27%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$577M
AUM Growth
+$577M
(+25%)
Cap. Flow
+$87.3M
Cap. Flow
% of AUM
15.13%
Top 10 Holdings %
Top 10 Hldgs %
35.5%
Holding
108
New
25
Increased
54
Reduced
16
Closed
13
Top Buys
| 1 |
Cencora
COR
|
$16.6M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$15.9M |
| 3 |
Becton Dickinson
BDX
|
$11.6M |
| 4 |
Danaher
DHR
|
$10.9M |
| 5 |
Insulet
PODD
|
$8.45M |
Top Sells
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$10.5M |
| 2 |
Elevance Health
ELV
|
$9.95M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$9.72M |
| 4 |
Eli Lilly
LLY
|
$9.5M |
| 5 |
IQVIA
IQV
|
$9.08M |
Sector Composition
| 1 | Healthcare | 98.94% |
| 2 | Industrials | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
X4 Pharmaceuticals
XFOR
$70M
| $7.31M | 1.27% |
125,553
+32,315
| +35% | +$1.88M |
|
27
89bio
ETNB
$1.37B
| $6.61M | 1.15% |
348,875
+101,919
| +41% | +$1.93M |
|
28
Ionis Pharmaceuticals
IONS
$9.64B
| $6.28M | 1.09% |
153,052
+1,891
| +1% | +$77.6K |
|
29
Arcellx
ACLX
$3.95B
| $6.17M | 1.07% |
195,260
+47,614
| +32% | +$1.51M |
|
|
CTLT
30
DELISTED
CATALENT, INC.
CTLT
| $6.12M | 1.06% |
+141,250
| New | +$6.12M |
|
31
Supernus Pharmaceuticals
SUPN
$2.52B
| $5.72M | 0.99% |
190,179
+58,301
| +44% | +$1.75M |
|
32
TG Therapeutics
TGTX
$5.03B
| $5.48M | 0.95% |
220,634
-55,007
| -20% | -$1.37M |
|
33
Veracyte
VCYT
$2.41B
| $5.4M | 0.94% |
211,960
+93,338
| +79% | +$2.38M |
|
34
Sutro Biopharma
STRO
$85.6M
| $5.32M | 0.92% |
1,143,861
+43,823
| +4% | +$204K |
|
35
Day One Biopharmaceuticals
DAWN
$766M
| $5.11M | 0.89% |
428,279
+28,059
| +7% | +$335K |
|
36
Humana
HUM
$37.5B
| $4.99M | 0.87% |
11,160
-6,677
| -37% | -$2.99M |
|
37
Inspire Medical Systems
INSP
$2.53B
| $4.7M | 0.81% |
+14,470
| New | +$4.7M |
|
|
BCYC
38
Bicycle Therapeutics
BCYC
$492M
| $4.4M | 0.76% |
172,285
+24,486
| +17% | +$625K |
|
39
Syndax Pharmaceuticals
SNDX
$1.39B
| $4.36M | 0.76% |
+208,266
| New | +$4.36M |
|
|
SGEN
40
DELISTED
Seagen Inc. Common Stock
SGEN
| $4.35M | 0.75% |
22,602
-50,498
| -69% | -$9.72M |
|
41
Pacific Biosciences
PACB
$378M
| $4.33M | 0.75% |
+325,500
| New | +$4.33M |
|
42
Maximus
MMS
$4.99B
| $4.26M | 0.74% |
+50,381
| New | +$4.26M |
|
43
Immunovant
IMVT
$2.91B
| $4.11M | 0.71% |
216,868
+30,823
| +17% | +$585K |
|
44
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $4.11M | 0.71% |
291,703
+41,446
| +17% | +$584K |
|
45
MoonLake Immunotherapeutics
MLTX
$3.78B
| $4.08M | 0.71% |
+80,000
| New | +$4.08M |
|
46
Establishment Labs
ESTA
$1.11B
| $3.99M | 0.69% |
58,083
+33,083
| +132% | +$2.27M |
|
|
PHLT
47
Performant Healthcare, Inc. Common Stock
PHLT
$602M
| $3.91M | 0.68% |
1,446,415
-107,460
| -7% | -$290K |
|
48
NeoGenomics
NEO
$1.06B
| $3.79M | 0.66% |
+235,847
| New | +$3.79M |
|
49
SI-BONE Inc
SIBN
$700M
| $3.75M | 0.65% |
+138,915
| New | +$3.75M |
|
50
Cullinan Oncology
CGEM
$456M
| $3.73M | 0.65% |
346,781
+176,895
| +104% | +$1.9M |
|